Nelson-Piercy, Catherine
Vlaev, Ivo
Harris, Katie
Fischer-Betz, Rebecca http://orcid.org/0000-0002-1058-7357
Funding for this research was provided by:
UCB
Article History
Received: 9 May 2019
Accepted: 29 October 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CNP has received speaker fees from Sanofi Aventis, Leo Pharma, UCB, Alliance Pharma, Warner Chilcott and consultancy fees from UCB Pharma and Alliance Pharma.RFB has received consulting fees, speaking fees and/or honoraria from Abbvie, BMS, Celgene, Chugai, GSK, Janssen, Lilly, Medac, MSD, Novartis, Roche, UCB Pharma and Pfizer.IV has received consulting fees and speaking fees from UCB Pharma.KH declares no conflict of interest.